Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings in Brief: January 8, 2014

BioMarin, BMS, Catalyst, Merck, NPS, Pacira, Repros, Rexahn

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
Rexahn begins solid tumor trial . . . read more

Phase III
Catalyst, BioMarin post positive Firdapse results . . . read more

Repros’ Androxal in head-to-head testosterone trial . . . read more

Phase IV
Exparel performs strongly against IV PCA opioid . . . read more

Filings
EMA accepts HCV MAA from BMS . . . read more

NPS BLA accepted for hypoparathyroidism . . . read more

Approvals
Merck HIV treatment approved in oral suspension . . . read more

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters